Elena V. Tozliyan

Elena V. Tozliyan

Auto-generated profile, based on publicly available information

Elena V. Tozliyan

Scientific Research Clinical Institute of Pediatrics and Pediatrics Surgery named after Acad.Yu.E. Veltischev, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2023 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
IAInga V. Anisimova
Inga V. Anisimova
SASvetlana Artemyeva
Svetlana Artemyeva
EBElena D. Belousova
Elena D. Belousova
NVNato D. Vashakmadze
Nato D. Vashakmadze
DVDmitry Vladimirovich Vlodavets
Dmitry Vladimirovich Vlodavets
ESEkaterina V. Shreder
Ekaterina V. Shreder
Duchenne muscular dystrophy is one of the most common forms of childhood muscular dystrophies. Its incidence is 1 in 3.5–6 thousand newborn boys according to various sources. The disease is caused by the mutation in the DMD gene coding the dystrophin protein, it leads to the dystrophin absence or malfunction. The disease is characterized by proximal muscle weakness and gastrocnemius muscles pseudohypertrophy. In average, patients lose the ability to walk by themselves by the age of 11 and become nonambulatory. The authors have present modern epidemiological data and etiopathogenesis features of Duchenne muscular dystrophy, and have described clinical signs of different disease stages. The algorithm and key points of differential diagnosis are indicated. Special attention was given to the patients’ management: pathogenetic treatment and rehabilitation of pediatric patients.

15 June 2017 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
NMNadezhda V. Makazan
Nadezhda V. Makazan
EOElizaveta M. Orlova
Elizaveta M. Orlova
ETElena V. Tozliyan
Elena V. Tozliyan
MMMaria Melikyan
Maria Melikyan
MKMaria A. Kareva
Maria A. Kareva
МАМеликян Мария Арменаковна
Меликян Мария Арменаковна
Background. Pseudohypoparathyroidism (PHP) is a heterogeneous group of disorders associated with tissue insensitivity to parathyroid hormone. PHP is characterized by genetic heterogeneity and variable phenotype. In addition to the hypocalcemic syndrome and resistance to parathyroid hormone, PHP is also characterized by phenotypic features and resistance to other hormones (TSH, LH, FSH, and GHRH), which are known as Albright Hereditary Osteodystrophy (AHO). Until recently, no analysis of large cohorts of patients with PHP has been performed in Russian literature. Objective — to examine a large cohort of patients with PHP and assess the clinical features of PHP. Material and methods. A group consisting of 32 patients with different variants of course of the disease who had been examined at the Endocrinology Research Center in 2014—2016 was analyzed. Results. Features of AHO phenotype in addition to hormonal resistance were identified in 16 (50%) patients; one of them had one feature (brachydactyly) and 15 patients had two and more features of AHO. Besides insensitivity to PTH, TSH resistance was found in 22 (68.75%) patients and one patient had resistance to PTH, TSH and LH/FSH. Hypothyroidism manifested before hypocalcaemia in 4 patients. Obesity was the first complaint in 8 patients; 5 of them had subclinical hypocalcaemia and the remaining 3 patients had an elevated PTH level with the normal level of calcium at the time of first examination. The most typical clinical signs of hypocalcaemia in 23 (72%) patients were seizures. Thirteen of them were misdiagnosed with epilepsy and had been followed by a neurologist for a period ranging between 2 months and 7 years before hypocalcaemia was revealed. Conclusions. Pseudohypoparathyroidism is a rare genetic disorder associated with resistance to parathyroid hormone, which can have a lot of other clinical features in addition to the symptoms of PTH resistance. Obesity or hypothyroidism can be the earliest manifestation of PHP preceding hypocalcaemia. Evaluation of serum calcium level is important for all pediatric patients with seizures to timely diagnose hypocalcaemia and avoid misdiagnosing.

2 August 2023 in Journal Of Nephrology
Verified
Journal Article
Closed access
PDF file
MAMarina Aksenova
Marina Aksenova
NZNatalia Zaikova
Natalia Zaikova
ETElena Tozliyan
Elena Tozliyan

4 August 2025 in Russian Journal of Child Neurology
Verified
Journal Article
Open access
PDF file
DVDmitry Vladimirovich Vlodavets
Dmitry Vladimirovich Vlodavets
SASvetlana Artemyeva
Svetlana Artemyeva
ETE. V. Tozliyan
E. V. Tozliyan
ASA. K. Shulchenko
A. K. Shulchenko
Duchenne muscular dystrophy (DMD) is an X-linked hereditary disease that manifests in early childhood and progresses with age, leading to loss of mobility and respiratory and cardiac failure. The globally recognized gold standard for DMD treatment is corticosteroids. However, until recently, only deflazacort (Emflaza) had received approval from the U.S. Food and Drug Administration (FDA) for the indication of DMD. All other drugs in this group were used off-label. At the end of 2023, the FDA, followed by the European Medicines Agency (EMA), registered another drug from the corticosteroid group – vamorolone (Agamree). In 2024, vamorolone received approval in the United Kingdom and China. Thus, all leading global regulators currently recognize vamorolone as a corticosteroids for the treatment of DMD.

15 December 2023 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
TGT.A. Gremyakova
T.A. Gremyakova
IAI.V. Anisimova
I.V. Anisimova
SASvetlana Artemyeva
Svetlana Artemyeva
EBE.N. Baybarina
E.N. Baybarina
ABA.A. Baranov
A.A. Baranov
MRMoscow State Duma Of The Federal Assembly Of Russia
Moscow State Duma Of The Federal Assembly Of Russia
Вам открыли доступ к файлу. Отправлено с помощью Облако Mail.ru.